• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白、肠道超声及其联合应用于炎症性肠病的诊断

Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of inflammatory bowel disease.

作者信息

Dubian Serge, Yzet Clara, Brazier Franck, Yzet Thierry, Hautefeuille Vincent, Decrombecque Catherine, Bocquillon Quentin, Richard Nicolas, Buisson Anthony, Meynier Jonathan, Fumery Mathurin

机构信息

Department of Gastroenterology, Amiens University hospital, and Université de Picardie, France.

Department of Radiology, Amiens University hospital, and Université de Picardie, France.

出版信息

Clin Res Hepatol Gastroenterol. 2025 Mar;49(3):102549. doi: 10.1016/j.clinre.2025.102549. Epub 2025 Feb 3.

DOI:10.1016/j.clinre.2025.102549
PMID:39909306
Abstract

BACKGROUND

We aimed to evaluate the diagnostic accuracy of fecal calprotectin (FC) and intestinal ultrasound (IUS), independently and in combination, as screening tools for adults with suspected IBD to reduce the number of unnecessary endoscopic procedures.

METHODS

We conducted a retrospective monocentric study that included consecutive adult patients with (i) ileocolonoscopy for suspected IBD between January 2021 and June 2023 who had either (ii) IUS and/or (iii) a FC test within 6 weeks. Bowel wall thickness (BWT) and the color Doppler signal (CDS) were evaluated for all segments. The presence of lymphadenopathy, loss of stratification, stricture, and fistula were also recorded.

RESULTS

In total, 119 patients with a median age of 32 years (IQR, 24.0-41.0) were included. The most common symptoms were abdominal pain (n = 88, 75 %) and chronic diarrhea (n = 89, 75 %). Among the 119 patients, 74 (62 %) had IUS, 101 (82 %) had a FC test, and 56 (47 %) had both. Forty patients (34 %) had a diagnosis of IBD, including 31 (26 %) with CD and 9 (8 %) with UC. By ROC curve analysis, the best threshold of FC to diagnose IBD was 117 ug/g (Se 97 %, Sp 73 %, PPV 67 %, NPV 98 %, AUC 0.88, 95 %CI [0.81; 0.94], p = 0.006). Using this threshold, only 3 % of patients were misclassified as non-IBD. Screening by measuring FC levels would result in a 48 % reduction in the number of adults requiring endoscopy. Abnomal IUS was significantly associated with a diagnosis of IBD (OR 5.6, 95 %IC [2.1;16.2], P = 0.0008). The association of a BWT>3 mm and a positive CDS was associated with a Se, Sp, PPV, and NPV of 48 %, 100 %, 100 %, and 75 %, respectively, but 52 % of patients were misclassified as non-IBD. The combination of a BWT>3 mm, CDS, and FC>117 ug/g had a Se, Sp, PPV, and NPV of 44 %, 100 %, 100 %, and 69 %, respectively. For patients with a normal IUS and FC<117 ug/g, 4 % were misclassified as non-IBD.

CONCLUSIONS

The combination of FC and IUS is a useful screening strategy to identify patients who truly require endoscopy for suspected IBD. Calprotectin is a highly effective test for ruling out IBD. Conversely, relying solely on IUS lacks the discriminative power to safely rule out IBD. However, it shows a high PPV and is a potent tool for diagnosing IBD.

摘要

背景

我们旨在评估粪便钙卫蛋白(FC)和肠道超声(IUS)单独及联合作为疑似炎症性肠病(IBD)成人患者筛查工具的诊断准确性,以减少不必要的内镜检查数量。

方法

我们进行了一项回顾性单中心研究,纳入了2021年1月至2023年6月期间因疑似IBD接受回结肠镜检查的连续成年患者,这些患者在6周内进行了(ii)IUS和/或(iii)FC检测。对所有肠段评估肠壁厚度(BWT)和彩色多普勒信号(CDS)。还记录了淋巴结病、分层消失、狭窄和瘘管的存在情况。

结果

共纳入119例患者,中位年龄32岁(四分位间距,24.0 - 41.0)。最常见的症状是腹痛(n = 88,75%)和慢性腹泻(n = 89,75%)。119例患者中,74例(62%)进行了IUS检查,101例(82%)进行了FC检测,56例(47%)两者都做了。40例(34%)患者被诊断为IBD,其中31例(26%)为克罗恩病(CD),9例(8%)为溃疡性结肠炎(UC)。通过ROC曲线分析,诊断IBD的FC最佳阈值为117μg/g(敏感性97%,特异性73%,阳性预测值67%,阴性预测值98%,曲线下面积0.88,95%置信区间[0.81; 0.94],p = (此处原文有误,推测应该是 = 0.0006))。使用该阈值,只有3%的患者被误诊为非IBD。通过检测FC水平进行筛查将使需要内镜检查的成人数量减少48%。异常IUS与IBD诊断显著相关(比值比5.6,95%置信区间[2.1; 16.2],P = 0.0008)。BWT>3mm和CDS阳性的联合诊断敏感性、特异性、阳性预测值和阴性预测值分别为48%﹑100%﹑100%和75%,但52%的患者被误诊为非IBD。BWT>3mm、CDS和FC>117μg/g的联合诊断敏感性、特异性、阳性预测值和阴性预测值分别为44%﹑100%﹑100%和69%。对于IUS正常且FC<117μg/g的患者,4%被误诊为非IBD。

结论

FC和IUS联合是一种有用的筛查策略,可识别真正需要因疑似IBD进行内镜检查的患者。钙卫蛋白是排除IBD的高效检测方法。相反,仅依靠IUS缺乏安全排除IBD的鉴别能力。然而,它显示出较高的阳性预测值,是诊断IBD的有力工具。

相似文献

1
Fecal calprotectin, intestinal ultrasound, and their combination for the diagnosis of inflammatory bowel disease.粪便钙卫蛋白、肠道超声及其联合应用于炎症性肠病的诊断
Clin Res Hepatol Gastroenterol. 2025 Mar;49(3):102549. doi: 10.1016/j.clinre.2025.102549. Epub 2025 Feb 3.
2
Noninvasive testing in the management of children with suspected inflammatory bowel disease.疑似炎症性肠病患儿管理中的无创检测
Scand J Gastroenterol. 2019 May;54(5):586-591. doi: 10.1080/00365521.2019.1604799. Epub 2019 Apr 28.
3
Non-invasive evaluation of mucosal healing by intestinal ultrasound or fecal calprotectin is efficient in Crohn's disease: A cross-sectional study.通过肠道超声或粪便钙卫蛋白对克罗恩病黏膜愈合进行无创评估是有效的:一项横断面研究。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102387. doi: 10.1016/j.clinre.2024.102387. Epub 2024 May 27.
4
Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.粪便钙卫蛋白检测对成人和儿童炎症性肠病诊断的有效性和成本效益。
Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.
5
Intestinal ultrasound at diagnosis of pediatric inflammatory bowel disease compared to endoscopy.小儿炎症性肠病诊断时肠道超声与内镜检查的比较
J Pediatr Gastroenterol Nutr. 2025 Mar;80(3):440-445. doi: 10.1002/jpn3.12444. Epub 2024 Dec 24.
6
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
7
The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.粪便钙卫蛋白在疑似小儿炎症性肠病中的诊断准确性。
Am J Gastroenterol. 2012 Jun;107(6):941-9. doi: 10.1038/ajg.2012.33. Epub 2012 Feb 28.
8
Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.快速粪便钙卫蛋白检测评估炎症性肠病内镜下疾病活动度:一项诊断队列研究
Saudi J Gastroenterol. 2015 Nov-Dec;21(6):360-6. doi: 10.4103/1319-3767.170948.
9
Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.粪便钙卫蛋白是儿童炎症性肠病患者疾病活动的有用标志物。
Dig Dis Sci. 2011 Aug;56(8):2372-7. doi: 10.1007/s10620-011-1633-y. Epub 2011 Mar 11.
10
Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.印度炎症性肠病患者粪便钙卫蛋白及其与炎症标志物和内镜检查的相关性
Indian J Gastroenterol. 2015 Nov;34(6):431-5. doi: 10.1007/s12664-015-0608-x. Epub 2015 Nov 21.

引用本文的文献

1
Patient Satisfaction with IBD Undergoing Colonoscopy: A Multicenter Cross-Sectional Study.接受结肠镜检查的炎症性肠病患者的满意度:一项多中心横断面研究
J Clin Med. 2025 Apr 8;14(8):2562. doi: 10.3390/jcm14082562.